{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:15:42Z","timestamp":1759940142981},"reference-count":91,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T00:00:00Z","timestamp":1148428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemophilia is a congenital disorder due to the deficiency of the activity of factor VIII (classical hemophilia A) or IX (Christmas disease or hemophilia B). Bleeding is common and may result in long\u2010term complications or even death. Bleeding may be treated or prevented by infusion of factor concentrates however these drugs are not without risk. Clinicians often feel ill prepared to provide accurate and impartial information regarding these drugs. This review will provide the reader with an historical yet up to date perspective on blood safety as it relates to the choice of concentrates to treat hemophilia. Pediatr Blood Cancer 2006;47:245\u2013254. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.20895","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T17:31:11Z","timestamp":1148491871000},"page":"245-254","source":"Crossref","is-referenced-by-count":6,"title":["Blood safety and the choice of anti\u2010hemophilic factor concentrate"],"prefix":"10.1002","volume":"47","author":[{"given":"Leonard A.","family":"Valentino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeral M.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,5,24]]},"reference":[{"key":"e_1_2_9_2_2","unstructured":"MASAC recommendations concerning the treatment of hemophilia and other bleeding disorders.National Hemophilia Foundation;2003Nov 2003. Report nr 151."},{"key":"e_1_2_9_3_2","unstructured":"Clinical Practice Guidelines.Hemophilia and von Willebrand's Disease (2. Management; Update 2): Association of Hemophlia Clinic Directors of Canada;1999July 1999. Report."},{"key":"e_1_2_9_4_2","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1001\/jama.1989.03420230088032","article-title":"The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy","volume":"261","author":"Pierce GF","year":"1989","journal-title":"JAMA"},{"key":"e_1_2_9_5_2","unstructured":"BrookerM.Treatment Products Supply Update. Safety and Supply News. Vol. 2002 (ed 1): World Federation of Hemophilia;2002."},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2001.00133.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00049.x"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00046.x"},{"key":"e_1_2_9_9_2","first-page":"441","article-title":"Safety of therapeutic products used for hemophilia patients","volume":"37","author":"MMWR Series","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.260.7.901"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3600"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204070-00002"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra031087"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.36.5.577"},{"key":"e_1_2_9_15_2","first-page":"1152","article-title":"Blood safety monitoring among persons with bleeding disorders\u2013United States","volume":"51","author":"MMWR Series","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_16_2","unstructured":"Centers for Disease Control and Prevention. Report on the Universal Data Collection Program. In:Prevention CfDCa editor. Volume 7.2005."},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000180163.84271.5e"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/00313029600169324"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106073442306"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2283"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613925"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(03)80740-0"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/tm.2001.25379"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.5.541"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1665410"},{"key":"e_1_2_9_26_2","first-page":"2428","article-title":"A multicenter study of recombinant factor VIII (recombinate): Safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group","volume":"83","author":"Bray GL","year":"1994","journal-title":"Blood"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655957"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7933.2004.00646.x"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6873.306"},{"key":"e_1_2_9_30_2","first-page":"16","article-title":"CDC\/hemophilia study targets blood safety and joint disease. Centers for Disease Control and Prevention","volume":"7","author":"Colvin R","year":"1997","journal-title":"Common Factor"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68036-7"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-6892.2004.00496.x"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb00356.x"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199612000-00024"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410202"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.81423-0"},{"key":"e_1_2_9_37_2","first-page":"80","article-title":"Current status of viral safety of virus inactivated factor VIII and IX concentrates in treatment of hemophilia","volume":"21","author":"Pollmann H","year":"1994","journal-title":"Infusionsther Transfusionsmed"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00612.x"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00901.x"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/368382"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.06.003"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.3.1101-1108.2004"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.04017"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.3.485-505.2002"},{"key":"e_1_2_9_45_2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH04-04-0229","article-title":"Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2","volume":"92","author":"Schneider B","year":"2004","journal-title":"Thromb Haemost"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04029.x"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7765"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.3177"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.11.5161-5167.2000"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2571"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01048.x"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5248.505"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3401"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-12-200006200-00006"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/313702"},{"key":"e_1_2_9_56_2","first-page":"55","article-title":"GB virus\u2010C\/hepatitis G virus","volume":"54","author":"Abe K","year":"2001","journal-title":"Jpn J Infect Dis"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00496.x"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01194.x"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1086\/342329"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24268"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.26.021304.144536"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/425035a"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15137"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0041-1132.2003.00586.x"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02719-7"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.t01-1-00351.x"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2002.100112.x"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00982.x"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12632-3"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524043360591"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.30125"},{"key":"e_1_2_9_74_2","first-page":"564","article-title":"Transmissible Spongiform Encephalopathies. Managing risk in mammalian organs, cells and sera","volume":"2","author":"Bailey AC","year":"1999","journal-title":"IDrugs"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38998409000.x"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(99)90067-1"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41040449.x"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00216.x"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01196.x"},{"key":"e_1_2_9_80_2","unstructured":"WHO.Cumulative number of reported cases of severe acute respiratory syndrome (SARS);.2003."},{"key":"e_1_2_9_81_2","first-page":"525","article-title":"Update: Severe acute respiratory syndrome\u2014United States, 2003","author":"MMWR Series","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_82_2","first-page":"516","article-title":"Update: Influenza Activity\u2014United States and Worldwide, 2002\u201303 Season, and Composition of the 2003\u201304 Influenza Vaccine","volume":"22","author":"CDC","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_9_83_2","unstructured":"WHO.Avian influenza Update\u2010May 19th 2005.2005."},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05168.x"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(92)70178-3"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302183280701"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983823"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(92)70176-X"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01774533"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01774522"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32664"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200418040-00002"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.20895","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.20895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:22:17Z","timestamp":1697167337000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.20895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,24]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1002\/pbc.20895"],"URL":"https:\/\/doi.org\/10.1002\/pbc.20895","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,24]]}}}